Insider Transactions Reported by 11 Insiders of 60 DEGREES PHARMACEUTICALS, INC.

Symbol
SXTP, SXTPW on Nasdaq
Location
Washington, DC

Insiders trading volume in the past year

60 DEGREES PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Knight Therapeutics Inc Former 10% Owner $5,475,241 28 Jul 2023
KENTUCKY TECHNOLOGY INC. 10%+ Owner $196,875 11 Jul 2023
Florida State University Research Foundation Inc. 10%+ Owner $151,875 11 Jul 2023
Geoffrey S. Dow President and CEO, Director $47,837 +$19,964 +72% 15 Dec 2025
Cheryl Xu Director $45,866 +$14,410 +46% 03 Jun 2025
Tyrone Miller Cfo $38,237 17 Jan 2025
Kristen Landon Chief Operating Officer $11,713 17 Jan 2025
Charles W. Allen Director $4,622 31 Dec 2023
Paul Field Director $4,014 31 Dec 2023
Stephen Toovey Director $4,014 31 Dec 2023
Bryan Lee Smith Chief Medical Officer 11 Jul 2023

Recent Insider Transactions by Companies or Individuals for 60 DEGREES PHARMACEUTICALS, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Geoffrey S. Dow SXTP Common Stock Purchase 19.4% $7,759 $0.8024 9,670 59,618 15 Dec 2025 Direct
Geoffrey S. Dow SXTP Common Stock Purchase 7.8% $3,318 $0.9184 3,613 49,948 11 Dec 2025 Direct
Geoffrey S. Dow SXTP Common Stock Purchase 25.3% $8,886 $0.9504 9,350 46,335 10 Dec 2025 Direct
Geoffrey S. Dow SXTP Common Stock Award 27.5% 7,201 33,372 12 Sep 2025 Direct
Geoffrey S. Dow SXTP Common Stock Award 20.1% 4,376 26,171 09 Jun 2025 Direct
Cheryl Xu SXTP Common Stock Purchase 46.2% $14,410 $2.88 5,000 15,816 03 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.